Affordable Access

deepdyve-link
Publisher Website

Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting.

Authors
  • Eleftheriadou, Maria1
  • Vazquez-Alfageme, Clara1
  • Citu, Cristina Maria1
  • Crosby-Nwaobi, Roxanne1
  • Sivaprasad, Sobha1
  • Hykin, Philip1
  • Hamilton, Robin D1
  • Patel, Praveen J2
  • 1 NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom. , (United Kingdom)
  • 2 NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom. Electronic address: [email protected] , (United Kingdom)
Type
Published Article
Journal
American journal of ophthalmology
Publication Date
Feb 01, 2017
Volume
174
Pages
160–168
Identifiers
DOI: 10.1016/j.ajo.2016.09.038
PMID: 27746298
Source
Medline
License
Unknown

Abstract

The VA and SDOCT results compare favorably with outcomes seen in randomized controlled trials. The results suggest that good long-term outcomes can be achieved using aflibercept for nAMD in clinical settings.

Report this publication

Statistics

Seen <100 times